Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Simmonds

Showing results (91-100 of 401) with videos related to

Pageof 41
Sort By:
Blood|March 1, 1982
Leukemic-like membrane properties acquired by B lymphocytes when depleted of 185,000-dalton macromolecular insoluble cold globulinM A Simmonds, G Sobczak, S P Hauptman
Current Opinion in Clinical Nutrition and Metabolic Care|December 23, 2021
Recent advances in policy and practice translation of the evidence for additional omega-3 fatty acids and prematurityLucy A Simmonds, Philippa F Middleton, Maria Makrides
Pediatric Nephrology (Berlin, Germany)|February 1, 1993
Gout, uric acid and purine metabolism in paediatric nephrologyJ S Cameron, F Moro, H A Simmonds
Advances in Experimental Medicine and Biology|January 1, 1991
What is the pathogenesis of familial gouty nephropathy?J S Cameron, F Moro, H A Simmonds
British Journal of Pharmacology|May 1, 1973
Microiontophoretic release of drugs from micropipettes: use of 24Na as a modelG Clarke, R G Hill, M A Simmonds
Clinical Science and Molecular Medicine|July 1, 1975
Variations in allopurinol metabolism by xanthinuric subjectsH A Simmonds, B Levin, J S Cameron
The American Journal of Physiology|June 1, 1991
Dopamine modulation of prolactin and vasopressin but not behavior on satiation of sheepF R Bell, S L Lightman, A Simmonds
Journal of Inherited Metabolic Disease|July 1, 1997
Familial renal disease or familial juvenile hyperuricaemic nephropathy?M B McBride, H A Simmonds, F Moro
Archives of Pathology & Laboratory Medicine|December 1, 1983
Mucin and fat emboli in mucinous carcinomas. Cause of hemorrhagic cerebral infarctsJ Towfighi, M A Simmonds, E A Davidson
Immunology Today|June 4, 1999
Novel mechanism for the impairment of cell proliferation in HIV-1 infectionM Bofill, N J Borthwick, H A Simmonds
Pageof 41

Showing results (91-100 of 401) with videos related to

Sort By:
Pageof 41
Blood|March 1, 1982
Leukemic-like membrane properties acquired by B lymphocytes when depleted of 185,000-dalton macromolecular insoluble cold globulinM A Simmonds, G Sobczak, S P Hauptman
Current Opinion in Clinical Nutrition and Metabolic Care|December 23, 2021
Recent advances in policy and practice translation of the evidence for additional omega-3 fatty acids and prematurityLucy A Simmonds, Philippa F Middleton, Maria Makrides
Pediatric Nephrology (Berlin, Germany)|February 1, 1993
Gout, uric acid and purine metabolism in paediatric nephrologyJ S Cameron, F Moro, H A Simmonds
Advances in Experimental Medicine and Biology|January 1, 1991
What is the pathogenesis of familial gouty nephropathy?J S Cameron, F Moro, H A Simmonds
British Journal of Pharmacology|May 1, 1973
Microiontophoretic release of drugs from micropipettes: use of 24Na as a modelG Clarke, R G Hill, M A Simmonds
Clinical Science and Molecular Medicine|July 1, 1975
Variations in allopurinol metabolism by xanthinuric subjectsH A Simmonds, B Levin, J S Cameron
The American Journal of Physiology|June 1, 1991
Dopamine modulation of prolactin and vasopressin but not behavior on satiation of sheepF R Bell, S L Lightman, A Simmonds
Journal of Inherited Metabolic Disease|July 1, 1997
Familial renal disease or familial juvenile hyperuricaemic nephropathy?M B McBride, H A Simmonds, F Moro
Archives of Pathology & Laboratory Medicine|December 1, 1983
Mucin and fat emboli in mucinous carcinomas. Cause of hemorrhagic cerebral infarctsJ Towfighi, M A Simmonds, E A Davidson
Immunology Today|June 4, 1999
Novel mechanism for the impairment of cell proliferation in HIV-1 infectionM Bofill, N J Borthwick, H A Simmonds
Pageof 41